Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$4.65bn	212.43	n/a
MSBMesoblast	AU$3.55bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$1.00bn	n/a	n/a
PYCPYC Therapeutics	AU$859.12m	n/a	n/a
IMMImmutep	AU$547.65m	n/a	n/a
RACRacura Oncology	AU$462.16m	n/a	n/a
CGSCogstate	AU$386.84m	26.17	0.86%
DXBDimerix	AU$359.11m	n/a	n/a
NYRNyrada	AU$179.28m	n/a	n/a
ACWActinogen Medical	AU$177.92m	n/a	n/a
TTXTetratherix	AU$175.66m	n/a	n/a
PEBPacific Edge	NZ$162.52m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$122.67m	n/a	n/a
ILAIsland Pharmaceuticals	AU$107.42m	n/a	n/a
ALAArovella Therapeutics	AU$96.27m	n/a	n/a
LTPLtr Pharma	AU$91.39m	n/a	n/a
BXNBioxyne	AU$84.43m	17.11	n/a
ATHAlterity Therapeutics	AU$82.15m	n/a	n/a
PIQProteomics International Laboratories	AU$80.13m	n/a	n/a
PTXPrescient Therapeutics	AU$71.67m	n/a	n/a